Interestingly, we found that, although most of the mutants tested were robustly cleaved during apoptosis, one of the mutants, the RASopathy‐derived MEK1(Y130C), was completely resistant to cleavage, indicating that Y130C mutation prevents MEK1 from caspase‐dependent proteolytic inhibition. Here, MAP2K1 is linked to RASopathy.